Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

First-in-class experimental CAR T-cell therapy shows promise against solid tumors

Researchers with the Charbonneau Cancer Institute at the University of Calgary and McMaster University have identified a unique target present on a specific group of solid cancerous tumors.

2 Jul 2026

Review highlights strong safety and effectiveness of mRNA vaccines

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly effective at preventing infectious diseases, including COVID-19.

30 Jun 2026

First-in-human trial tests safer T-cell therapy for pediatric brain cancers

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National using a new T-cell immunotherapy for children and young adults with some of the deadliest brain tumors, including diffuse intrinsic pontine glioma (DIPG) and relapsed central nervous system (CNS) tumors.

30 Jun 2026

Fourier 80: bringing benchtop NMR systems to the laboratory

Benchtop NMR puts nuclear magnetic resonance on the lab bench, supporting teaching, QC, reaction monitoring, and materials research.

From Bruker BioSpin Group 30 Jun 2026

AI-guided microneedle patch changes shape to heal chronic wounds

Chronic wounds remain a major healthcare challenge, especially for people with diabetes, who often experience delayed healing, persistent inflammation, and a higher risk of infection.

26 Jun 2026

Aston University receives funding to develop unique cancer-fighting 'magnetobots'

Aston University has been awarded €1.2m through the Marie Skłodowska-Curie Actions (MSCA) Staff Exchanges program for a project bringing together 18 partner organizations to develop unique cancer-fighting 'magnetobots'.

25 Jun 2026

Merck KGaA, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 25 Jun 2026

New chemistry database helps speed up global drug discovery

Developing new medicines can require thousands of chemistry experiments to identify the right recipe for a safe, effective and ideally affordable drug.

22 Jun 2026

How electrical engineering ensures accurate calibration and patient safety

Discover how electrical engineering supports calibration accuracy, device reliability, and patient safety in critical healthcare applications.

From Mesa Labs, Inc. 22 Jun 2026

How industrial hygiene flow calibration supports defensible exposure data

Discover expert insights into industrial hygiene flow calibration, sampling integrity, and defensible exposure data for workplace safety.

From Mesa Labs, Inc. 22 Jun 2026

Engineers identify usability barriers in workplace exoskeleton systems

Wearable exoskeletons can help reduce physical strain in the workplace and protect employees from injury, but the technology has yet to achieve widespread adoption. A new study published in PLOS One by engineers at The University of Texas at El Paso may explain why: The technology is still too complex and cumbersome for everyday use.

17 Jun 2026

Salt-loaded nanoparticles help deliver fragile gene therapies into cells

Researchers at the University of Houston's College of Pharmacy have discovered an unexpected simple strategy to improve the performance of mRNA vaccines and gene therapeutics: adding salt.

16 Jun 2026

Synthetic cooling agents in e-cigarettes link to abnormal heartbeats

Synthetic cooling ingredients added to e-cigarettes caused abnormal heartbeats (arrhythmias) and increased cardiovascular risk measures in mice and lab-grown human heart cells, according to new independent research published today in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal of the American Heart Association.

15 Jun 2026

The importance of ketones from a clinical and medical perspective

In this interview, News-Medical talks to Marcin Pacek, senior director of medical and scientific affairs in Europe for Nova Biomedical, about the importance of ketones in a medical and clinical setting.

From Nova Biomedical 15 Jun 2026

New mRNA flu vaccine offers broader protection against influenza strains

A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today's standard flu shot, offering stronger and potentially longer-lasting protection.

15 Jun 2026

AI could help food systems detect pathogens, fraud, and contamination faster

A systematic review of 161 peer-reviewed publications found that AI research in food safety has expanded rapidly, rising from one study in 2012 to 46 in 2023. The review shows that machine learning and deep learning are being studied for pathogen detection, chemical contamination prediction, food fraud screening, outbreak surveillance, and regulatory decision-making, but data gaps, class imbalance, privacy limits, and model interpretability remain major barriers.

15 Jun 2026

NHS pathology staff face unsafe formaldehyde exposure levels

Routine exposure to harmful levels of the human tissue preservative formaldehyde are risking the health of thousands of NHS staff working in pathology departments across the UK, due to poor monitoring and control, finds an analysis of Freedom of Information (FOI) requests, published online in the journal Occupational & Environmental Medicine.

9 Jun 2026

Experimental two‑in‑one vaccine shows success in human LASSARAB trial

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.

9 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

Infant receives world's first gene therapy for WOREE syndrome

An eight-month-old infant with a severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene directly in the brain.

8 Jun 2026